Randomized comparative study of the effects of treatment with once-daily, niacin extended-release/lovastatin and with simvastatin on lipid profile and fibrinolytic parameters in Taiwan (Q79773529)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 June 2006

Language	Label	Description	Also known as
English	Randomized comparative study of the effects of treatment with once-daily, niacin extended-release/lovastatin and with simvastatin on lipid profile and fibrinolytic parameters in Taiwan	scientific article published on 01 June 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16793562%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Randomized comparative study of the effects of treatment with once-daily, niacin extended-release/lovastatin and with simvastatin on lipid profile and fibrinolytic parameters in Taiwan (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16793562%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Tsung-Hsien Lin

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16793562%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16793562%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Wen-Chol Voon

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16793562%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Hsueh-Wei Yen

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16793562%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Chih-Hsin Huang

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16793562%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Wen-Ter Lai

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16793562%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Sheng-Hsiung Sheu

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16793562%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

1 June 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16793562%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Kaohsiung Journal of Medical Sciences

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16793562%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16793562%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16793562%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

257-265

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16793562%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

1 reference

https://api.crossref.org/works/10.1016%2FS1607-551X%2809%2970309-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS1607-551X%2809%2970309-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of statin therapy in adults with coronary heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1607-551X%2809%2970309-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

1 reference

https://api.crossref.org/works/10.1016%2FS1607-551X%2809%2970309-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes

1 reference

https://api.crossref.org/works/10.1016%2FS1607-551X%2809%2970309-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review

1 reference

https://api.crossref.org/works/10.1016%2FS1607-551X%2809%2970309-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS1607-551X%2809%2970309-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS1607-551X%2809%2970309-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Existing and investigational combination drug therapy for high-density lipoprotein cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS1607-551X%2809%2970309-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism of action of niacin on lipoprotein metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1607-551X%2809%2970309-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Statins: effective antiatherosclerotic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1607-551X%2809%2970309-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of lovastatin (20 mg) and nicotinic acid (1.2 g) with either drug alone for type II hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1607-551X%2809%2970309-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS1607-551X%2809%2970309-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of once-daily, niacin extended-release/lovastatin with standard doses of atorvastatin and simvastatin (the ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation [ADVOCATE]).

1 reference

https://api.crossref.org/works/10.1016%2FS1607-551X%2809%2970309-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS1607-551X%2809%2970309-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hypercholesterolemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1607-551X%2809%2970309-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Nicotinic acid-induced fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS1607-551X%2809%2970309-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Niacin hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1607-551X%2809%2970309-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The pleiotropic effects of statins.

1 reference

https://api.crossref.org/works/10.1016%2FS1607-551X%2809%2970309-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Statin therapy: having the good without the bad.

1 reference

https://api.crossref.org/works/10.1016%2FS1607-551X%2809%2970309-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Attenuation of the synthesis of plasminogen activator inhibitor type 1 by niacin. A potential link between lipid lowering and fibrinolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1607-551X%2809%2970309-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1607-551X(09)70309-2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16793562%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16793562%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79773529&oldid=2234539955"